We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Morphologically-Directed Raman Spectroscopy as an Analytical Method for Subvisible Particle Characterization in Therapeutic Protein Product Quality
Summary
Researchers tested a method called Morphologically-Directed Raman Spectroscopy (MDRS) to identify and chemically characterize tiny particles in injectable drug products, successfully identifying over 90% of particles between 19 and 100 micrometers. This technique could improve quality control for pharmaceuticals and has parallels to methods used to identify microplastic particles in environmental samples.
Subvisible particles (SVPs) are a critical quality attribute of injectable therapeutic proteins (TPs) that needs to be controlled due to potential risks associated with drug product quality. The current compendial methods routinely used to analyze SVPs for lot release provide information on particle size and count. However, chemical identification of individual particles is also important to address root-cause analysis. Herein, we introduce Morphologically-Directed Raman Spectroscopy (MDRS) for SVP characterization of TPs. The following particles were used for method development: (1) polystyrene microspheres, a traditional standard used in industry; (2) photolithographic (SU-8); and (3) ethylene tetrafluoroethylene (ETFE) particles, candidate reference materials developed by NIST. In our study, MDRS rendered high-resolution images for the ETFE particles (> 90%) ranging from 19 to 100 μm in size, covering most of SVP range, and generated comparable morphology data to flow imaging microscopy. Our method was applied to characterize particles formed in stressed TPs and was able to chemically identify individual particles using Raman spectroscopy. MDRS was able to compare morphology and transparency properties of proteinaceous particles with reference materials. The data suggests MDRS may complement the current TPs SVP analysis system and product quality characterization workflow throughout development and commercial lifecycle.
Sign in to start a discussion.
More Papers Like This
Screening for subvisible particles in pharmaceutical formulations – a case study
This study applied flow imaging microscopy to detect and characterize subvisible particles in pharmaceutical formulations — a quality control challenge that shares methodological overlap with microplastic detection. Improved particle characterization methods in the pharmaceutical sector can also advance techniques for identifying nanoplastics in biological and environmental samples.
Identification of Microplastics Using a Custom Built Micro-Raman Spectrometer
Researchers built a custom micro-Raman spectrometer and demonstrated its use for identifying microplastic polymer types in environmental samples, achieving sensitive and specific polymer identification at particle sizes down to a few micrometers.
Raman Diffusion-Ordered Spectroscopy
Researchers combined Raman spectroscopy with diffusion-based size measurement to simultaneously identify and size molecules in a single experiment. This technique could be adapted to characterize nanoplastic particles by their chemical identity and size, both of which determine their biological behavior and toxicity.
Raman Microspectroscopy: Improvement in Signal Generation and Collection to Facilitate Raman Spectroscopy
Advances in Raman microspectroscopy were reviewed for improving signal generation and analysis in microplastic identification, including new detector designs and data processing algorithms. Enhanced Raman spectroscopy capabilities enable faster and more accurate polymer identification at smaller particle sizes.
Surface-Enhanced Raman Spectroscopy Facilitates the Detection of Microplastics <1 μm in the Environment
Researchers developed a method using surface-enhanced Raman spectroscopy to detect and identify individual microplastic particles smaller than one micrometer. This technique addresses a major gap in environmental monitoring, since most current methods cannot reliably detect the smallest microplastics that may pose the greatest risk due to their ability to enter cells and tissues.